Doc, let me ask you this: what pops into your head when you hear “neuroleptics” (you know, those drugs used to treat schizophrenia)? I bet you’re thinking most neuroleptics can handle positive symptoms like hallucinations pretty well, but negative symptoms? That’s a tougher nut to crack. We’re talking flat affect, lack of motivation, and the...
The digital revolution has flooded the internet with a vast amount of information, but more data doesn’t guarantee investment success. The key is high-quality information. That’s why I turn to the timeless wisdom of iconic investors like John Templeton, Warren Buffett, and his mentors, Ben Graham and Phil Fisher, adapting their principles to biotech investing....
Continuing the theme of this blog, doctors and healthcare professionals have a unique edge in biotech investing, but you need to integrate that insight into a robust investing framework. This newsletter serves to help you with that integration. So, if you haven’t read my prior article on this topic, I encourage you to check it...
Yesterday, I shared Why Physicians and Healthcare Providers Make Great Biotech Investors. The takeaway? As a physician, your deep medical and scientific training puts you on the front lines of clinical care, giving you a unique edge in spotting breakthrough developments before they hit the radar. Here’s a perfect example that proves it. I recently...
As physicians and healthcare providers, you’ve spent years in medical school and clinical practice mastering medicine, biostatistics, and more. But let’s be real—investing and finance? Those weren’t part of the curriculum. So, you might think biotech investing is out of your league, something reserved for Wall Street wizards. That’s conventional wisdom. And it’s dead wrong....
At Evergrowth BioHealthcare Capital, we believe the key to successful investing lies in understanding a stock’s intrinsic value—the true worth of a company based on its fundamentals, not fleeting market sentiment. For young growth biotech stocks, intrinsic value is dynamic, evolving with each milestone in their journey from lab to market. Let’s explore how this...
Evergrowth Biohealthcare Capital recognizes the immense potential of digital health to reshape the healthcare landscape. We are actively seeking investment opportunities in companies that are developing innovative digital health solutions that are: Evergrowth BioHealthcare Capital is committed to supporting the innovators driving the digital transformation of healthcare. We offer not only financial resources but also...
In the fast-paced world of biotech investing, people who understand both science and business and finances have a competitive advantage. Physicians and scientists with financial knowledge have a distinct advantage in selecting biotech stocks by combining their medical and scientific knowledge with financial savvy. Why does this matter? In the biotech business, the capacity to...